An Act providing for prohibitions on discriminatory actions by manufacturers or distributors of certain dru...
Families relying on 340B drugs may benefit from improved access.
Do you support it?
Want to know if it passes?
We'll email you when SB 1486 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on SB 1486.
You're tracking SB 1486
We'll email you the moment it moves.
SB 1486 — An Act providing for prohibitions on discriminatory actions by manufacturers or distributors of certain drugs and for reimbursement claims methodology; providing for grants for sexually transmitted disease clinics; imposing duties on the Department of Human Services and Office of Attorney General; and imposing penalties.
Last action — Referred to HEALTH AND HUMAN SERVICES, Oct. 13, 2026
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill is in committee in the Senate. Introduced October 13, 2026. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the Senate.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
-
In Committee
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (1 R).
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
In plain language
The bill prohibits discrimination against 340B drug access and alters reimbursement processes.
This bill aims to prevent discriminatory actions by drug manufacturers or distributors affecting 340B drug access and establishes reimbursement claim methodologies. It also includes provisions for grants related to sexually transmitted disease clinics.
What this means for you
- Families: Families relying on 340B drugs may benefit from improved access.
- Healthcare: Healthcare providers must comply with new access rules for 340B drugs.
Bill Text
- Printer's No. 2028 View text Current
Action History
-
Referred to HEALTH AND HUMAN SERVICES, Oct. 13, 2026
Sponsors
- Michele Brooks · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 252 not signed on
Sponsors (1)
- Michele Brooks Republican
Co-sponsors (0)
None.
Not signed on (252)
252 members have not signed on to this bill.
Show all 252 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- Who sponsors SB 1486?
- SB 1486 is sponsored by Michele Brooks (Republican).
- What is the current status of SB 1486?
- This bill is in committee in the Senate. Introduced October 13, 2026. It must pass committee before a floor vote.
- Where can I track SB 1486?
- Track SB 1486 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 1486
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 1486
Last checked for changes 16 days ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →